BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18069259)

  • 1. [Molecular mechanism of oncogenesis and progression in human myeloma].
    Kawano MM; Otsuyama K
    Nihon Rinsho; 2007 Dec; 65(12):2187-93. PubMed ID: 18069259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
    Jiang H; Gao W; Sze DM; Xiong H; Hou J
    Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
    Carrasco DR; Sukhdeo K; Protopopova M; Sinha R; Enos M; Carrasco DE; Zheng M; Mani M; Henderson J; Pinkus GS; Munshi N; Horner J; Ivanova EV; Protopopov A; Anderson KC; Tonon G; DePinho RA
    Cancer Cell; 2007 Apr; 11(4):349-60. PubMed ID: 17418411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
    Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
    Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.
    Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M
    Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pax-5 genes and CD19 molecules in human myeloma].
    Ishikawa H; Kawano M
    Rinsho Ketsueki; 2000 May; 41(5):404-7. PubMed ID: 10879100
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of Pax5 promotes plasma cell differentiation.
    Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
    Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of myeloma cell line differentiation induced by 2-methoxyestradiol].
    Gao WR; Hou J; Xiong H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):598-601. PubMed ID: 16532968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of Pax-5 gene in human myeloma cells.
    Mahmoud MS; Huang N; Nobuyoshi M; Lisukov IA; Tanaka H; Kawano MM
    Blood; 1996 May; 87(10):4311-5. PubMed ID: 8639790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of different spliceosomes of overexpressed XBP-1 on differentiation of myeloma cells].
    Zou JF; Jiang H; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1181-5. PubMed ID: 21129257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
    Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization.
    Jourdan M; Caraux A; De Vos J; Fiol G; Larroque M; Cognot C; Bret C; Duperray C; Hose D; Klein B
    Blood; 2009 Dec; 114(25):5173-81. PubMed ID: 19846886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Methoxyestradiol at low dose induces differentiation of myeloma cells.
    Hou J; Xiong H; Gao W; Jiang H
    Leuk Res; 2005 Sep; 29(9):1059-67. PubMed ID: 16038732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of clonotypic IgH VDJ sequences in multiple myeloma.
    Taylor BJ; Kriangkum J; Strachan ER; Wizniak J; Pilarski LM
    Methods Mol Med; 2005; 113():121-44. PubMed ID: 15968099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential functions of Pax-5 (BSAP) in pro-B cell development.
    Nutt SL; Thévenin C; Busslinger M
    Immunobiology; 1997 Dec; 198(1-3):227-35. PubMed ID: 9442394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol.
    Zhou X; Jiang H; Hou J
    Leuk Res; 2007 Sep; 31(9):1259-65. PubMed ID: 17257674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory mechanisms that determine the development and function of plasma cells.
    Calame KL; Lin KI; Tunyaplin C
    Annu Rev Immunol; 2003; 21():205-30. PubMed ID: 12524387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell lineage-specific activator protein (BSAP). A player at multiple stages of B cell development.
    Michaelson JS; Singh M; Birshtein BK
    J Immunol; 1996 Apr; 156(7):2349-51. PubMed ID: 8786288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.